Gad Thomas
Y-mAbs Therapeutics, Inc. · CHIEF BUSINESS OFFICER
Gad Thomas is listed in filings as CHIEF BUSINESS OFFICER at Y-mAbs Therapeutics, Inc.. This profile follows SEC Form 4 activity through Sep 18, 2025, including sale activity. Recent filings connect the profile to Y-mAbs Therapeutics, Inc. (YMAB). The current snapshot covers public activity from Jun 11, 2024 to Sep 18, 2025. Reported amounts are shown as $420.0K to $389.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $420k35k shares | SellJun 11, 2024 | $12.00 | $8.61 | |
| $421k35k shares | SellJun 10, 2024 | $12.03 | $8.61 | |
| $389k30k shares | SellSep 16, 2024 | $12.97 | $8.61 | |
| $876k65k shares | SellSep 13, 2024 | $13.47 | $8.61 |